DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced that company management is scheduled to participate at the following upcoming investor conferences:
November 6, 2019
· 1 min read